OTCMKTS:PTCHF PureTech Health (PTCHF) Stock Price, News & Analysis → 4x Better than Bitcoin (From Behind the Markets) (Ad) Free PTCHF Stock Alerts $2.82 -0.03 (-1.05%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$2.82▼$2.8250-Day Range$2.30▼$2.8552-Week Range$1.69▼$3.10Volume52,560 shsAverage Volume39,894 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get PureTech Health alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About PureTech Health Stock (OTCMKTS:PTCHF)PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies. It is also developing LYT-300, an oral allopregnanolone, currently completed Phase 1 stage, to treat depression, anxiety, and related indications; and LYT-310, an oral cannabidiol, currently under preclinical stage, to treat epilepsies and other neurological indications. In addition, the company is developing LYT-503/IMB-150, a non-opioid inflammation targeted disease immunomodulation for the potential treatment of interstitial cystitis, or bladder pain syndrome; and Glyph technology platform, a lymphatic-targeting chemistry platform, which leverages the body's natural lipid absorption and transports the process to orally administer drugs via the lymphatic system. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.Read More PTCHF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PTCHF Stock News HeadlinesMarch 23, 2024 | seekingalpha.comPureTech Health: Repeat What WorksMarch 23, 2024 | americanbankingnews.comPureTech Health (OTCMKTS:PTCHF) Trading Down 2.6%March 29, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 13, 2024 | lse.co.ukPureTech Health celebrates drug designation for LYT-200 from US FDAMarch 13, 2024 | markets.businessinsider.comPureTech Health Gets FDA's Orphan Drug Designation For LYT-200 In Acute Myeloid LeukemiaFebruary 24, 2024 | finance.yahoo.comPureTech Health plc (PTCHF)December 20, 2023 | finance.yahoo.comPureTech Year End Update and Outlook for 2024December 16, 2023 | morningstar.comPureTech Health PLC PRTCMarch 29, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…August 29, 2023 | lse.co.ukPureTech narrows interim loss despite "stormy market challenges"August 1, 2023 | marketwatch.comPureTech Health Gets $11.4Mln to Advance Development of LYT-300June 13, 2023 | finance.yahoo.comResults of PureTech's Annual General MeetingJune 7, 2023 | lse.co.ukPureTech Health's Akili launches ADHD immersive treatment in USMay 9, 2023 | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease WeekMay 4, 2023 | finance.yahoo.comPureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based TherapeuticApril 29, 2023 | finance.yahoo.comFull Year 2023 PureTech Health PLC Earnings CallApril 28, 2023 | lse.co.ukPureTech Health yearly loss widens but remains optimisticMarch 25, 2023 | proactiveinvestors.comNike, UBS, MGC Pharmaceuticals, NVIDIA, Travelzoo top the analyst calls of the weekMarch 21, 2023 | lse.co.ukPureTech Health says Karuna KArXT trial receives positive resultsFebruary 14, 2023 | finance.yahoo.comPureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum DepressionJanuary 21, 2023 | reuters.comPRTC.L - | Stock Price & Latest News | ReutersJanuary 13, 2023 | uk.finance.yahoo.comPureTech Health plc (PRTC.L)November 30, 2022 | msn.comPureTech Announces New Therapeutic Candidate LYT-310, An Oral CBD ProdrugNovember 30, 2022 | finance.yahoo.comPureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech’s Glyph™ PlatformNovember 1, 2022 | finance.yahoo.comPureTech to Present at the Credit Suisse 31st Annual Healthcare ConferenceOctober 13, 2022 | finance.yahoo.comThe Petri Dish: 1910 Genetics hires CBO; PureTech calls off mergerOctober 11, 2022 | lse.co.ukPureTech Health takeover talks with Nektar Therapeutics endSee More Headlines Receive PTCHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:PTCHF CUSIPN/A CIK1782999 Webwww.puretechhealth.com Phone(617) 482-2333FaxN/AEmployees111Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMs. Daphne Zohar (Age 53)Founder, CEO & Executive Director Comp: $1.01MDr. Bharatt M. Chowrira J.D. (Age 59)Ph.D., President & Executive Director Comp: $800.55kDr. Robert S. Langer Jr. (Age 75)Ph.D., Co-Founder & Non-Executive Director Comp: $145kDr. David R. Elmaleh Ph.D. (Age 76)Co-Founder & Senior Advisor Ms. Allison Mead TalbotHead of Communications & Investor RelationsMr. Spencer BallSenior Vice President of Human ResourcesDr. Eric Elenko Ph.D. (Age 51)Chief Innovation & Strategy Officer Ms. Aleksandra Filipovic M.D.Ph.D., Head of OncologyMs. Cheryl Murphy Ph.D.Head of Grants Management & StrategyMs. Anita Terpstra J.D.Ph.D., Senior VP & Head of Intellectual PropertyMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors PTCHF Stock Analysis - Frequently Asked Questions How have PTCHF shares performed in 2024? PureTech Health's stock was trading at $2.38 on January 1st, 2024. Since then, PTCHF stock has increased by 19.7% and is now trading at $2.85. View the best growth stocks for 2024 here. Are investors shorting PureTech Health? PureTech Health saw a increase in short interest in March. As of March 15th, there was short interest totaling 49,300 shares, an increase of 35.1% from the February 29th total of 36,500 shares. Based on an average daily trading volume, of 36,700 shares, the short-interest ratio is currently 1.3 days. View PureTech Health's Short Interest. How do I buy shares of PureTech Health? Shares of PTCHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PTCHF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.